oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Where Are We Now With Bilirubin as a Marker of Vascular Risk?
Örebro University Hospital. Department of Laboratory Medicine, Clinical Chemistry Unit, Örebro University Hospital, Örebro, Sweden.
2014 (English)In: Angiology, ISSN 0003-3197, E-ISSN 1940-1574, Vol. 65, no 3, p. 177-179Article in journal (Refereed) Published
Place, publisher, year, edition, pages
Sage Publications, 2014. Vol. 65, no 3, p. 177-179
National Category
Cardiac and Cardiovascular Systems
Identifiers
URN: urn:nbn:se:oru:diva-56346DOI: 10.1177/0003319713482747ISI: 000337971500001PubMedID: 23564018Scopus ID: 2-s2.0-84893570704OAI: oai:DiVA.org:oru-56346DiVA, id: diva2:1081798
Available from: 2017-03-15 Created: 2017-03-15 Last updated: 2018-06-19Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Breimer, Lars H.
By organisation
Örebro University Hospital
In the same journal
Angiology
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 1 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf